(Q36460295)

14 August 2017

Controlled trial of intermittent aerosol therapy with sodium 2-mercaptoethane sulphonate in cystic fibrosis (English)

1 reference

14 August 2017

0 references

1 reference

Weller PH

1

1 reference

14 August 2017

Ingram D

series ordinal

2

1 reference

14 August 2017

Preece MA

series ordinal

3

1 reference

14 August 2017

Matthew DJ

series ordinal

4

1 reference

14 August 2017

language of work or name

English

0 references

publication date

1 January 1980

1 reference

14 August 2017

1 reference

14 August 2017

35

1 reference

14 August 2017

1

1 reference

14 August 2017

42-46

1 reference

A rapid plethysmographic method for measuring thoracic gas volume: a comparison with a nitrogen washout method for measuring functional residual capacity in normal subjects

14 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=471218

Mist tent therapy of the obstructive pulmonary lesion of cystic fibrosis

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=471218

Ventilatory function in infants with cystic fibrosis. Physiological assessment of halation therapy

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=471218

The measurement of fluid deposition in humans following mist tent therapy

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=471218

Clinical and physiological evaluation of mucolytic agents nebulized with isoproterenol: 10% N-acetylcysteine versus 10% 2-mercaptoethane sulphonate

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=471218

An evaluation of nightly mist tent therapy for patients with cystic fibrosis

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=471218

Pulmonary deposition of aerosols in children with cystic fibrosis

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=471218

Evaluation of a new mucolytic drug

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=471218

Lung function in childhood: I. The forced expiratory volumes in healthy children using a spirometer and reverse plethysmograph

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=471218

N-acetylcysteine in cystic fibrosis. Mechanical and chemical factors in treatment by aerosol

28 June 2018

1 reference

12 December 2020

Mist therapy reconsidered; an evaluation of the respiratory deposition of labelled water aerosols produced by jet and ultrasonic nebulizers

1 reference

12 December 2020

Sputum liquefying agents: a comparative in vitro evaluation

1 reference

12 December 2020

Evaluation of mist tent therapy in cystic fibrosis using maximum expiratory flow volume curve

1 reference

12 December 2020

THE USE OF N-ACETYLCYSTEINE IN THE TREATMENT OF CYSTIC FIBROSIS

1 reference

12 December 2020

The systematic evaluation of the chest radiograph in cystic fibrosis

1 reference

12 December 2020

Identifiers

DOI

10.1136/THX.35.1.42

1 reference

14 August 2017

1 reference

14 August 2017

PubMed publication ID

6767295

1 reference